|Year : 2018 | Volume
| Issue : 8 | Page : 1080-1083
The protective effect of simvastatin against ultraviolet B-induced corneal endothelial cell death
Yi-Ru Ho1, Chih-Hung Lin2, Chan-Yen Kuo3
1 Department of Medical Research and Development, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan
2 Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan
3 Department of Biomedical Sciences and Engineering, Graduate Institute of Systems Biology and Bioinformatics, National Central University, Chungli; Department of Ophthalmology, Hsin Sheng Junior College of Medical Care and Management, Longtan, Taiwan
|Date of Submission||18-Jan-2018|
|Date of Acceptance||24-Apr-2018|
|Date of Web Publication||23-Jul-2018|
Dr. Chan-Yen Kuo
Department of Biomedical Sciences and Engineering, Graduate Institute of Systems Biology and Bioinformatics, National Central University, Chung-li
Source of Support: None, Conflict of Interest: None
Purpose: Excessive ultraviolet B (UVB) exposure causing corneal endothelium injury, including apoptosis, is a serious condition. Therefore, drugs that can inhibit apoptosis in corneal endothelial cells represent an effective strategy. Simvastatin is widely used as a specific inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase, can reduce levels of low density lipoprotein (LDL) cholesterol, and exerts anti-inflammatory effects. However, the protective effect of simvastatin on corneal endothelial cells remains unclear. Therefore, the aim of this study was to elucidate whether UVB promotes the initiation of apoptosis in corneal endothelial cells and injury reversible by simvastatin treatment. Methods: We detected the cell viability, subG1 population, and caspase-3 activity. Results: Results showed that simvastatin alleviates UVB-induced cell death, cell apoptosis, and caspase-3 activity. Conclusion: Our findings indicated that simvastatin alleviated UVB-induced corneal endothelial cell apoptosis via caspase-3 activity.
Keywords: Apoptosis, caspase-3 activity, corneal endothelium cells, simvastatin, ultraviolet B
|How to cite this article:|
Ho YR, Lin CH, Kuo CY. The protective effect of simvastatin against ultraviolet B-induced corneal endothelial cell death. Indian J Ophthalmol 2018;66:1080-3
|How to cite this URL:|
Ho YR, Lin CH, Kuo CY. The protective effect of simvastatin against ultraviolet B-induced corneal endothelial cell death. Indian J Ophthalmol [serial online] 2018 [cited 2020 May 24];66:1080-3. Available from: http://www.ijo.in/text.asp?2018/66/8/1080/237355
Yi-Ru Ho and Chih-Hung Lin:- These two authors have contributed equally to this work
Corneal edema is a common characteristic of acute or protracted corneal disease of various etiologies. Corneal transparency is primarily dependent on the ability of the cornea to remain in a dehydrated state. Importantly, the function of corneal endothelial cells is a major determinant of corneal hydration. Clinically, the corneal endothelial cell density has been considered a key indicator for evaluating and maintaining corneal health.,,
Ultraviolet (UV) light is the most common cause of radiation injury to the eye. The major function of the cornea is to absorb the majority of UV radiation. UV radiation damage to the corneal epithelium is cumulative, and UVB radiation presents a higher risk of pathogenesis than UVA.,, Increasing evidence indicates that UVB radiation from sunlight induces corneal inflammation or photokeratitis accompanied by changes in corneal hydration., Moreover, it has also been reported that exposure to high doses of UVB can cause corneal endothelium damage and may cause fluctuating or occasionally blurred vision.,, Therefore, preventing corneal endothelium degradation is considered an effective strategy for treating corneal edema.
Statins are potent cholesterol-lowering agents with broad anti-inflammatory properties. Morimoto et al. reported that lovastatin enhances the clearance of apoptotic cells in chronic obstructive pulmonary disease. Moreover, several studies have demonstrated that simvastatin exerts anti-inflammatory and antifibrotic effects in acute lung injury, inflammatory arthritis, and bleomycin-induced pulmonary fibrosis.,,, However, the effect of simvastatin in eye diseases remains unclear. Therefore, in this study, we examined the effect of simvastatin on corneal endothelial cells following UVB irradiation.
| Methods|| |
Bovine corneal endothelial (BCE) C/D-1b cells were procured from Bioresource Collection and Research Center and cultured under optimized conditions according to the supplier's instructions. Briefly, cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Gibco, New York, NY, USA) supplemented with 10% FBS, 25 mM D-glucose, 2 mM L-glutamine, 1 mM sodium pyruvate, and penicillin-streptomycin (50 U/mL; Sigma, St. Louis, MO, USA) at 37°C in 5% CO2/95% air. The culture medium was replaced with fresh medium on alternate days. Once the cells reached 70%–80% confluence, they were trypsinized and seeded onto 6- or 24-well plastic culture dishes for subsequent experiments.
Cell viability assay
Cell viability was measured using a WST-1 assay. Cells were seeded at a density of 5 × 104 cells/ml in 24-well plates and cultured in phenol red-free DMEM containing 0.5% heat-inactivated FBS for 24 h. Next, cells were incubated with indicated concentrations of simvastatin for 24 h. The WST-1 reagent was then added into the medium and the cells were incubated at 37°C for 2 h. The absorbance was measured at 450 nm in a microplate reader (BIO-RAD, Hercules, CA, USA).
Cell cycle analysis
Cells were treated with or without simvastatin in the presence or absence of UVB (10 mJ/cm 2) for 24 h before being harvested and fixed in ice-cold 70% ethanol for 1 h. Cells were then washed with phosphate-buffered saline and incubated in propidium iodide staining buffer (50 μg/ml propidium iodide, 0.1 mg/ml DNase-free RNase A, and 0.5% Triton X-100) for 30 min at 37°C in the dark. The DNA content was analyzed by flow cytometry (BD Biosciences, CA, USA).
Caspase-3 activity assay
The activity of caspase-3 was assayed using a caspase-3/CPP32 colorimetric assay kit. Briefly, cells were treated with oridonin for 2 h and then resuspended in cell lysis buffer (BioVision, Milpitas, CA, USA). Samples were centrifuged at 10,000 g for 5 min at 4°C to yield cell lysates. Protein concentrations of cell lysates were determined by the Bradford method using bovine serum albumin as a standard. The isolated supernatant was mixed with an equal volume of reaction buffer (containing 10 mM DTT and 400 μM DEVD-pNA) and incubated at 37°C for 120 min. The absorbance was measured at 450 nm in a microplate reader (BIO-RAD, USA).
Data are expressed as the mean ± standard error of the mean, and comparisons were statistically calculated by one-way or two-way analysis of variance followed by a Bonferroni post hoc test. P < 0.05 was considered statistically significant.
| Results|| |
Simvastatin alleviates ultraviolet B-induced cell death
UVB significantly induced cell death in BCE C/D-1b corneal endothelial cells according to the cell viability analysis [Figure 1]. To determine the effect of simvastatin on cell survival, cell viability was determined in cells treated with 0.5 μM simvastatin before UVB irradiation. Results showed that simvastatin significantly inhibited UVB-induced cell viability [Figure 1].
|Figure 1: Simvastatin reversed ultraviolet B-induced cell death. Cells were treated with control or 0.5 μM simvastatin for 24 h before ultraviolet B exposure. Following exposure for 24 h, cell viability was determined using a WST-1 assay. All data are presented as the mean ± standard error of the mean (n = 3). *P < 0.05, **P < 0.01|
Click here to view
Simvastatin inhibits ultraviolet B-induced endothelial cell apoptosis and caspase-3 activity
To further determine whether UVB-induced cell death through apoptosis, cell cycle, and caspase-3 activity were evaluated. UVB caused an increase in cells in the sub-G1 phase, which is an indicator of apoptosis. Furthermore, simvastatin reversed the UVB-induced increase in the sub-G1 population [Figure 2].
|Figure 2: Protective effect of simvastatin against ultraviolet B-induced cell apoptosis. (a) Changes in the sub-G1 phase population were determined following treatment with control or simvastatin (0.5 μM) before ultraviolet B exposure. (b) Representative sub-G1 populations calculated from flow-activated cell sorting histograms are shown (n = 3). All data are presented as the mean ± standard error of the mean (n = 3). *P < 0.05|
Click here to view
Caspase-3 plays a central role in the apoptotic response. Our results showed that caspase-3 activity was significantly increased after UVB irradiation, but that this effect was reversed in the presence of simvastatin [Figure 3]. These findings indicate that UVB-induced apoptosis in BCE C/D-1b corneal endothelial cells through a caspase-3 dependent pathway.
|Figure 3: Simvastatin inhibited ultraviolet B-induced caspase-3 activity. Cells were treated with control or 0.5 μM simvastatin for 24 h before ultraviolet B exposure for a further 24 h. Caspase-3 activity was measured using a caspase-3/CPP32 colorimetric assay kit (n = 3). *P < 0.05|
Click here to view
| Discussion|| |
The importance of taking appropriate precautions to protect the eyes from the increasing levels of UV radiation reaching the Earth's surface through stratospheric ozone layer depletion has been established. Recent studies demonstrated that corneal epithelial stem cells reside preferentially in the basal layer of the peripheral cornea in the limbal zone, rather than uniformly in the entire corneal epithelium., Therefore, it is imperative to develop agents capable of preventing corneal damage caused by UVB irradiation.
Simvastatin is a widely used specific inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase and can reduce the level of low-density lipoprotein cholesterol as well as exert anti-inflammatory effects., A previous clinical study has demonstrated that simvastatin may be associated with visual field stabilization in patients with normal tension glaucoma. A larger scale randomized controlled trial and cost-effective analyses seem to be approved. Moreover, statins have been shown to reduce ocular inflammation in animal models of uveitis and to prevent the development of uveitis in observational studies. Shirinsky et al. reported that simvastatin may have therapeutic potential in noninfectious uveitis; however, these results need to be confirmed in double-blinded, randomized, and controlled studies. Furthermore, Harris et al. reported a lack of strong evidence of any adverse effects on lens opacity formation following 18 months of simvastatin treatment. Therefore, the effect of simvastatin in eye diseases remains conflicting.
UVB overexposure is the most common cause of radiation damage to the eyeball and is a risk factor for human corneal damage., Photokeratitis and UV keratitis are eye diseases associated with UVB-induced corneal damage. The cellular and molecular mechanisms involved in photokeratitis and UV keratitis have already been reported.,, Accumulating evidence reported that UVB-induced corneal cell apoptosis in vitro and in vivo.,,, Moreover, many studies ,,,,,, have revealed that UVB radiation causes mouse corneal tissue abnormalities. Therefore, studying of the potential protective molecule is important in developing better remedial strategies for corneal endothelial cell damage through apoptosis. The aim of this study was to investigate the protective effects of simvastatin against UVB-induced corneal apoptosis. Consistent with our results in this study, Zheng et al. also demonstrated that simvastatin has a protective effect on apoptosis caused by diabetics in bovine retinal capillary endothelial cells and associated with poly (adp-ribose) polymerase activity. Consequently, we proposed that simvastatin ameliorated UVB-induced corneal endothelial cell to apoptosis. However, further evidence is necessary to confirm this observation.
| Conclusion|| |
Our results indicate that simvastatin exerts a protective effect against UVB-induced corneal endothelial cell apoptosis through caspase-3 activation.
Financial support and sponsorship
This work was supported by grants from the RD107019 from Show Chwan and Chan Bing Show Chwan Memorial Hospital, Changhua, Taiwan.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Costagliola C, Romano V, Forbice E, Angi M, Pascotto A, Boccia T, et al.
Corneal oedema and its medical treatment. Clin Exp Optom 2013;96:529-35.
Bourne WM. Biology of the corneal endothelium in health and disease. Eye (Lond) 2003;17:912-8.
Bourne WM, McLaren JW. Clinical responses of the corneal endothelium. Exp Eye Res 2004;78:561-72.
Tomaszewski BT, Zalewska R, Mariak Z. Evaluation of the endothelial cell density and the central corneal thickness in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Ophthalmol 2014;2014:123683.
Taylor HR. The biological effects of UV-B on the eye. Photochem Photobiol 1989;50:489-92.
Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA, et al.
Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989;107:1481-4.
DePry J, Brescoll J, Szczotka-Flynn L, Rambhatla P, Lim HW, Cooper K, et al.
Phototherapy-related ophthalmologic disorders. Clin Dermatol 2015;33:247-55.
Cejka C, Luyckx J, Cejková J. Central corneal thickness considered an index of corneal hydration of the UVB irradiated rabbit cornea as influenced by UVB absorber. Physiol Res 2012;61:299-306.
Delic NC, Lyons JG, Di Girolamo N, Halliday GM. Damaging effects of ultraviolet radiation on the cornea. Photochem Photobiol 2017;93:920-9.
Doughty MJ, Oblak E. A clinical assessment of the anterior eye in arc welders. Clin Exp Optom 2005;88:387-95.
Golu A, Gheorghişor I, Bălăşoiu AT, Baltă F, Osiac E, Mogoantă L, et al.
The effect of ultraviolet radiation on the cornea – Experimental study. Rom J Morphol Embryol 2013;54:1115-20.
Schönbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: Statins as antiinflammatory agents? Circulation 2004;109:II18-26.
Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, et al.
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 2006;176:7657-65.
Grommes J, Vijayan S, Drechsler M, Hartwig H, Mörgelin M, Dembinski R, et al.
Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One 2012;7:e38917.
Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z, et al.
Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci 2012;13:8293-307.
Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, et al.
A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003;170:1524-30.
McMichael AJ; World Health Organization. Climate Change and Human Health: Risks and Responses. Geneva: World Health Organization; 2003. p. xi, 322.
Sun TT, Lavker RM. Corneal epithelial stem cells: Past, present, and future. J Investig Dermatol Symp Proc 2004;9:202-7.
Sun TT, Tseng SC, Lavker RM. Location of corneal epithelial stem cells. Nature 2010;463:E10-1.
Kotyla P. The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology. Ther Adv Musculoskelet Dis 2010;2:257-69.
Venturi E, Lindsay C, Lotteau S, Yang Z, Steer E, Witschas K, et al.
Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform. Br J Pharmacol 2018;175:938-52.
Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS, et al.
Simvastatin and disease stabilization in normal tension glaucoma: A cohort study. Ophthalmology 2010;117:471-6.
Borkar DS, Tham VM, Shen E, Parker JV, Uchida A, Vinoya AC, et al.
Association between statin use and uveitis: Results from the Pacific ocular inflammation study. Am J Ophthalmol 2015;159:707-13.
Shirinsky IV, Biryukova AA, Shirinsky VS. Simvastatin as an adjunct to conventional therapy of non-infectious uveitis: A randomized, open-label pilot study. Curr Eye Res 2017;42:1713-8.
Harris ML, Bron AJ, Brown NA, Keech AC, Wallendszus KR, Armitage JM, et al.
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group. Br J Ophthalmol 1995;79:996-1002.
Kolozsvári L, Nógrádi A, Hopp B, Bor Z. UV absorbance of the human cornea in the 240- to 400-nm range. Invest Ophthalmol Vis Sci 2002;43:2165-8.
Schein OD. Phototoxicity and the cornea. J Natl Med Assoc 1992;84:579-83.
Kennedy M, Kim KH, Harten B, Brown J, Planck S, Meshul C, et al.
Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997;38:2483-91.
Alexander G, Carlsen H, Blomhoff R. Corneal NF-kappaB activity is necessary for the retention of transparency in the cornea of UV-B-exposed transgenic reporter mice. Exp Eye Res 2006;82:700-9.
Pauloin T, Dutot M, Joly F, Warnet JM, Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 2009;15:577-83.
Ubels JL, Glupker CD, Schotanus MP, Haarsma LD. Involvement of the extrinsic and intrinsic pathways in ultraviolet B-induced apoptosis of corneal epithelial cells. Exp Eye Res 2016;145:26-35.
Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, et al.
Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci 2013;14:2175-89.
Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, et al.
Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis 2012;18:455-64.
Chang SW, Chou SF, Chuang JL. Mitomycin C potentiates ultraviolet-related cytotoxicity in corneal fibroblasts. Cornea 2008;27:686-92.
Newkirk KM, Chandler HL, Parent AE, Young DC, Colitz CM, Wilkie DA, et al.
Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
Ibrahim OM, Kojima T, Wakamatsu TH, Dogru M, Matsumoto Y, Ogawa Y, et al.
Corneal and retinal effects of ultraviolet-B exposure in a soft contact lens mouse model. Invest Ophthalmol Vis Sci 2012;53:2403-13.
Tao X, Yu H, Zhang Y, Li Z, Jhanji V, Ni S, et al.
Role of corneal epithelium in riboflavin/ultraviolet-A mediated corneal cross-linking treatment in rabbit eyes. Biomed Res Int 2013;2013:624563.
Chen BY, Lin DP, Wu CY, Teng MC, Sun CY, Tsai YT, et al.
Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation. Mol Vis 2011;17:854-63.
Chen BY, Lin DP, Chang LS, Huang TP, Liu HJ, Luk CP, et al.
Dietary α-lipoic acid prevents UVB-induced corneal and conjunctival degeneration through multiple effects. Invest Ophthalmol Vis Sci 2013;54:6757-66.
Lin DP, Chang HH, Yang LC, Huang TP, Liu HJ, Chang LS, et al.
Assessment of ultraviolet B-blocking effects of weekly disposable contact lenses on corneal surface in a mouse model. Mol Vis 2013;19:1158-68.
Shao YC, Liou JC, Kuo CY, Tsai YS, Lin EC, Hsieh CJ, et al.
UVB promotes the initiation of uveitic inflammatory injury in vivo
and is attenuated by UV-blocking protection. Mol Vis 2017;23:219-27.
Zheng Z, Chen H, Wang H, Ke B, Zheng B, Li Q, et al.
Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha. Diabetes 2010;59:2315-25.
[Figure 1], [Figure 2], [Figure 3]